Therapeutic Properties of Green Tea: A Review

Authors

  • Sonia Ratnani Chemistry Department, Ramjas College, University of Delhi, Delhi-110007 (India)
  • Sarika Malik Chemistry Department, Ramjas College, University of Delhi, Delhi-110007 (India)

DOI:

https://doi.org/10.47352/jmans.2774-3047.117

Keywords:

green tea, polyphenols, human health, antioxidant

Abstract

The most consumed beverage in the world is tea after water. Till today the consumption of black tea is 70% while that of green tea is only 20%. One reason for this percentage is lack of awareness about green tea and invested research. Green tea along with caffeine which imparts characteristic taste, bitterness and stimulating effect, is also rich in a group of chemicals, called catechin polyphenols (commonly known as tannins, which contribute to bitter taste and astringency) and deliver antioxidant properties. Furthermore, green tea also comprises of amino acids such as Theanine along with alkaloids such as adenine, dimethylxanthine, theobromine, theophylline, and xanthine. Some vitamins, like vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin C and vitamin E are also found in green tea. The present review gives the study of various constituents of green tea and their impact on human health. Studies provide strong evidence that owing to antioxidant properties daily intake of green tea may be used as a preventive measure for different types of cancer and other diseases. This review gives a detailed analysis of constituents of green tea and highlighting it's potential as a natural nutraceutical. However, although much of the documented literature mentions positive effect yet much had to be explored on correlation between concentration of green tea and toxicity.

References

[1] H. N. Graham. (1992). “Green tea composition, consumption, and polyphenol chemistry”. Preventive Medicine. 21 (3): 334–350. 10.1016/0091-7435(92)90041-F.

[2] R. Wierzejska. (2014). “Tea and health--a review of the current state of knowledge”. Przegla̧d epidemiologiczny. 68 (3).

[3] S. Kuriyama. (2008). “The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies”. Journal of Nutrition. 138 (8). 10.1093/jn/138.8.1548s.

[4] V. R. Sinija and H. N. Mishra. (2008). “Green tea: Health benefits”. Journal of Nutritional & Environmental Medicine. 17 (4): 232–242. 10.1080/13590840802518785.

[5] S. Khokhar and S. G. M. Magnusdottir. (2002). “Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom”. Journal of Agricultural and Food Chemistry. 50 (3): 565–570. 10.1021/jf010153l.

[6] Y. S. Lin, Y. J. Tsai, J. S. Tsay, and J. K. Lin. (2003). “Factors affecting the levels of tea polyphenols and caffeine in tea leaves”. Journal of Agricultural and Food Chemistry. 51 (7): 1864–1873. 10.1021/jf021066b.

[7] O. Asbaghi, F. Fouladvand, M. J. Gonzalez, D. Ashtary-Larky, R. Choghakhori, and A. Abbasnezhad. (2021). “Effect of green tea on glycemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis”. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 15 (1): 23–31. 10.1016/j.dsx.2020.11.004.

[8] R. J. Geiser, S. E. Chastain, and M. A. Moss. (2017). “Regulation of Bace1 Mrna Expression in Alzheimer’S Disease by Green Tea Catechins and Black Tea Theaflavins”. Biophysical Journal. 112 (3): 362a. 10.1016/j.bpj.2016.11.1965.

[9] M. Cascella, S. Bimonte, M. R. Muzio, V. Schiavone, and A. Cuomo. (2017). “The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: An overview of pre-clinical studies and translational perspectives in clinical practice”. Infectious Agents and Cancer. 12 (1): 10.1186/s13027-017-0145-6.

[10] H. J., W. D., C. J., and S. A. (2018). “The safety of green tea and green tea extract consumption in adults – Results of a systematic review”. Regulatory Toxicology and Pharmacology. 95 : 412–433.

[11] Q. V. Vuong. (2014). “Epidemiological Evidence Linking Tea Consumption to Human Health: A Review”. Critical Reviews in Food Science and Nutrition. 54 (4): 523–536. 10.1080/10408398.2011.594184.

[12] L. Zeng, X. Wang, Y. Liao, D. Gu, F. Dong, and Z. Yang. (2019). “Formation of and changes in phytohormone levels in response to stress during the manufacturing process of oolong tea (Camellia sinensis)”. Postharvest Biology and Technology. 157 : 110974. 10.1016/j.postharvbio.2019.110974.

[13] Z.-T. Fang, C.-J. Song, H.-R. Xu, and J.-H. Ye. (2019). “Dynamic changes in flavonol glycosides during production of green, yellow, white, oolong and black teas from Camellia sinensis L. (cv. Fudingdabaicha)”. International Journal of Food Science & Technology. 54 (2): 490–498. 10.1111/ijfs.13961.

[14] M. I. Prasanth, B. S. Sivamaruthi, C. Chaiyasut, and T. Tencomnao. (2019). “A review of the role of green tea (camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy”. Nutrients. 11 (2). 10.3390/nu11020474.

[15] W. C. Reygaert. (2018). “Green tea catechins: Their use in treating and preventing infectious diseases”. BioMed Research International. 2018. 10.1155/2018/9105261.

[16] F. Li, Y. Wang, D. Li, Y. Chen, X. Qiao, R. Fardous, A. Lewandowski, J. Liu, T. H. Chan, and Q. P. Dou. (2018). “Perspectives on the recent developments with green tea polyphenols in drug discovery”. Expert Opinion on Drug Discovery. 13 (7): 643–660. 10.1080/17460441.2018.1465923.

[17] C. Cabrera, R. Artacho, and R. Giménez. (2006). “Beneficial Effects of Green Tea—A Review”. Journal of the American College of Nutrition. 25 (2): 79–99. 10.1080/07315724.2006.10719518.

[18] L. S. Lee, S. H. Kim, Y. B. Kim, and Y. C. Kim. (2014). “Quantitative analysis of major constituents in green tea with different plucking periods and their antioxidant activity”. Molecules. 19 (7): 9173–9186. 10.3390/molecules19079173.

[19] C. Chu, J. Deng, Y. Man, and Y. Qu. (2017). “Green Tea Extracts Epigallocatechin-3-gallate for Different Treatments”. BioMed Research International. 2017. 10.1155/2017/5615647.

[20] T. . Yamamoto, L. R. . Juneja, D. . Chu, and M. Kim. (1997). “Chemistry and Applications of Green Tea”. Florida, CRC Press: Boca Raton.

[21] M. Reto, M. E. Figueira, H. M. Filipe, and C. M. M. Almeida. (2007). “Chemical composition of green tea (Camellia sinensis) infusions commercialized in Portugal”. Plant Foods for Human Nutrition. 62 (4): 139–144. 10.1007/s11130-007-0054-8.

[22] N. Donlao and Y. Ogawa. (2019). “The influence of processing conditions on catechin, caffeine and chlorophyll contents of green tea (Camelia sinensis) leaves and infusions.” LWT. 116 : 108567. 10.1016/j.lwt.2019.108567.

[23] A. Rietveld and S. Wiseman. (2003). “Antioxidant effects of tea: Evidence from human clinical trials”. Journal of Nutrition. 133 (10). 10.1093/jn/133.10.3285s.

[24] C. J. Dufresne and E. R. Farnworth. (2001). “A review of latest research findings on the health promotion properties of tea”. Journal of Nutritional Biochemistry. 12 (7): 404–421. 10.1016/S0955-2863(01)00155-3.

[25] P. V., A. M., D. S., H. G., and H. S.K. (2018). “A review on: Green tea: A miraculous drink”. International Journal of Pharmaceutical Sciences Review and Research. 51 (2): 26–34.

[26] C. Musial, A. Kuban-Jankowska, and M. Gorska-Ponikowska. (2020). “Beneficial properties of green tea catechins”. International Journal of Molecular Sciences. 21 (5). 10.3390/ijms21051744.

[27] Z. Y. Chen, Q. Y. Zhu, Y. F. Wong, Z. Zhang, and H. Y. Chung. (1998). “Stabilizing Effect of Ascorbic Acid on Green Tea Catechins”. Journal of Agricultural and Food Chemistry. 46 (7): 2512–2516. 10.1021/jf971022g.

[28] Z. Y. Chen, Q. Y. Zhu, D. Tsang, and Y. Huang. (2001). “Degradation of green tea catechins in tea drinks”. Journal of Agricultural and Food Chemistry. 49 (1): 477–482. 10.1021/jf000877h.

[29] V. Crespy and G. Williamson. (2004). “A review of the health effects of green tea catechins in in vivo animal models”. Journal of Nutrition. 134 (12). 10.1093/jn/134.12.3431s.

[30] M. W. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki, and M. Rath. (2005). “In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7”. Medical Oncology. 22 (2): 129–138. 10.1385/MO:22:2:129.

[31] R. M.W., R. N., I. V., K. T., N. A., and R. M. (2005). “Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis”. Oncology reports. 14 (4): 807–815.

[32] N. T. Zaveri. (2006). “Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications”. Life Sciences. 78 (18): 2073–2080. 10.1016/j.lfs.2005.12.006.

[33] J. S. Shim, M. H. Kang, Y. H. Kim, J. K. Roh, C. Roberts, and I. P. Lee. (1995). “Chemopreventive Effect of Green Tea (Camellia sinensis) among Cigarette Smokers”. Cancer Epidemiology Biomarkers and Prevention. 4 (4): 387–391.

[34] H. Mukhtar, Z. Y. Wang, S. K. Katiyar, and R. Agarwal. (1992). “Tea components: Antimutagenic and anticarcinogenic effects”. Preventive Medicine. 21 (3): 351–360. 10.1016/0091-7435(92)90042-G.

[35] Y. Shirakami and M. Shimizu. (2018). “Possible mechanisms of green tea and its constituents against cancer”. Molecules. 23 (9). 10.3390/molecules23092284.

[36] S. K. Abe and M. Inoue. (2021). “Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence”. European Journal of Clinical Nutrition. 75 (6): 865–876. 10.1038/s41430-020-00710-7.

[37] S. Hayakawa, T. Ohishi, N. Miyoshi, Y. Oishi, Y. Nakamura, and M. Isemura. (2020). “Anti-cancer effects of green tea epigallocatchin-3- gallate and coffee chlorogenic acid”. Molecules. 25 (19). 10.3390/molecules25194553.

[38] V. Conde, M. Alves, P. Oliveira, and B. Silva. (2014). “Tea (Camellia sinensis (L.)): A Putative Anticancer Agent in Bladder Carcinoma?”. Anti-Cancer Agents in Medicinal Chemistry. 15 (1): 26–36. 10.2174/1566524014666141203143143.

[39] M. Zhang, C. W. Binns, and A. H. Lee. (2002). “Tea consumption and ovarian cancer risk: A case-control study in China”. Cancer Epidemiology Biomarkers and Prevention. 11 (8): 713–718.

[40] G. Yang, W. Zheng, Y. B. Xiang, J. Gao, H. L. Li, X. Zhang, Y. T. Gao, and X. O. Shu. (2011). “Green tea consumption and colorectal cancer risk: A report from the shanghai men’s health study”. Carcinogenesis. 32 (11): 1684–1688. 10.1093/carcin/bgr186.

[41] J. M. Yuan. (2011). “Green tea and prevention of esophageal and lung cancers”. Molecular Nutrition and Food Research. 55 (6): 886–904. 10.1002/mnfr.201000637.

[42] H. Fritz, D. Seely, D. A. Kennedy, R. Fernandes, K. Cooley, and D. Fergusson. (2013). “Green tea and lung cancer: A systematic review”. Integrative Cancer Therapies. 12 (1): 7–24. 10.1177/1534735412442378.

[43] J. Wang, W. Zhang, L. Sun, H. Yu, Q. X. Ni, H. A. Risch, and Y. T. Gao. (2012). “Green tea drinking and risk of pancreatic cancer: A large-scale, population-based case-control study in urban Shanghai”. Cancer Epidemiology. 36 (6). 10.1016/j.canep.2012.08.004.

[44] Y. Miyata, Y. Shida, T. Hakariya, and H. Sakai. (2019). “Anti-cancer effects of green tea polyphenols against prostate cancer”. Molecules. 24 (1). 10.3390/molecules24010193.

[45] R. Somasundaram, A. Choraria, S. M. George, K. Narayanaswamy, K. Vasudevan, M. Antonysamy, and X. Zhang. (2019). “A preliminary pilot scale analysis of anti-cariogenic activity of green tea powder extract flavoured with Ginger, Cloves and Mint against clinical oral pathogens”. Clinical Nutrition Experimental. 24 : 66–71. 10.1016/j.yclnex.2018.12.002.

[46] N. Khan and H. Mukhtar. (2019). “Tea polyphenols in promotion of human health”. Nutrients. 11 (1). 10.3390/nu11010039.

[47] Q. P. Dou. (2019). “Tea in health and disease”. Nutrients. 11 (4). 10.3390/NU11040929.

[48] S. Ding, J. Jiang, P. Yu, G. Zhang, G. Zhang, and X. Liu. (2017). “Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy”. PLoS ONE. 12 (8). 10.1371/journal.pone.0181666.

[49] R. Xu, K. Yang, S. Li, M. Dai, and G. Chen. (2020). “Effect of green tea consumption on blood lipids: A systematic review and meta-analysis of randomized controlled trials”. Nutrition Journal. 19 (1). 10.1186/s12937-020-00557-5.

[50] H. M. Kim and J. Kim. (2013). “The effects of green tea on obesity and type 2 diabetes”. Diabetes and Metabolism Journal. 37 (3): 173–175. 10.4093/dmj.2013.37.3.173.

[51] X. Yin, J. Yang, T. Li, L. Song, T. Han, M. Yang, H. Liao, J. He, and X. Zhong. (2015). “The effect of green tea intake on risk of liver disease: A meta analysis”. International Journal of Clinical and Experimental Medicine. 8 (6): 8339–8346.

[52] A. B. Hodgson, R. K. Randell, and A. E. Jeukendrup. (2013). “The effect of green tea extract on fat oxidation at rest and during exercise: Evidence of efficacy and proposed mechanisms”. Advances in Nutrition. 4 (2): 129–140. 10.3945/an.112.003269.

[53] P. V. A. Babu, K. E. Sabitha, and C. S. Shyamaladevi. (2006). “Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats”. Chemico-Biological Interactions. 162 (2): 114–120. 10.1016/j.cbi.2006.04.009.

[54] D. L. McKay and J. B. Blumberg. (2002). “The Role of Tea in Human Health: An Update”. Journal of the American College of Nutrition. 21 (1): 1–13. 10.1080/07315724.2002.10719187.

[55] H. Lu, X. Meng, C. Li, S. Sang, C. Patten, S. Sheng, J. Hong, N. Bai, B. Winnik, C. T. Ho, and C. S. Yang. (2003). “Glucuronides of tea catechins: Enzymology of biosynthesis and biological activities”. Drug Metabolism and Disposition. 31 (4): 452–461. 10.1124/dmd.31.4.452.

[56] C. H. Wu, F. H. Lu, C. S. Chang, T. C. Chang, R. H. Wang, and C. J. Chang. (2003). “Relationship among habitual tea consumption, percent body fat, and body fat distribution”. Obesity Research. 11 (9): 1088–1095. 10.1038/oby.2003.149.

[57] Y. K. Yee, M. W. L. Koo, and M. L. Szeto. (2002). “Chinese tea consumption and lower risk of Helicobacter infection”. Journal of Gastroenterology and Hepatology (Australia). 17 (5): 552–555. 10.1046/j.1440-1746.2002.02718.x.

[58] K. Unno, F. Takabayashi, H. Yoshida, D. Choba, R. Fukutomi, N. Kikunaga, T. Kishido, N. Oku, and M. Hoshino. (2007). “Daily consumption of green tea catechin delays memory regression in aged mice”. Biogerontology. 8 (2): 89–95. 10.1007/s10522-006-9036-8.

[59] M. W. L. Koo and C. H. Cho. (2004). “Pharmacological effects of green tea on the gastrointestinal system”. European Journal of Pharmacology. 500 : 177–185. 10.1016/j.ejphar.2004.07.023.

[60] F. Takabayashi, N. Harada, M. Yamada, B. Murohisa, and I. Oguni. (2004). “Inhibitory effect of green tea catechins in combination with sucralfate on Helicobacter pylori infection in Mongolian gerbils”. Journal of Gastroenterology. 39 (1): 61–63. 10.1007/s00535-003-1246-0.

[61] M. Raekiansyah, C. C. Buerano, M. A. D. Luz, and K. Morita. (2018). “Inhibitory effect of the green tea molecule EGCG against dengue virus infection”. Archives of Virology. 163 (6): 1649–1655. 10.1007/s00705-018-3769-y.

[62] H. Tsuneki, M. Ishizuka, M. Terasawa, J. Bin Wu, T. Sasaoka, and I. Kimura. (2004). “Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans”. BMC Pharmacology. 4. 10.1186/1471-2210-4-18.

[63] M. Meydani. (2006). “Nutrition Interventions in Aging and Age-Associated Disease”. Annals of the New York Academy of Sciences. 928 (1): 226–235. 10.1111/j.1749-6632.2001.tb05652.x.

[64] M. Sano, Y. Takahashi, K. Yoshino, K. Shimoi, Y. Nakamura, I. Tomita, I. Oguni, and H. Konomoto. (1995). “Effect of Tea (Camellia Sinensis L.) on Lipid Peroxidation in Rat Liver and Kidney: A Comparison of Green and Black Tea Feeding”. Biological and Pharmaceutical Bulletin. 18 (7): 1006–1008. 10.1248/bpb.18.1006.

[65] J. Z. Conger and S. Singg. (2019). “Effects of Green Tea Consumption on Psychological Health”. Therapeutic Advances in Cardiology. 2 (2): 251–255.

[66] E. Mancini, C. Beglinger, J. Drewe, D. Zanchi, U. E. Lang, and S. Borgwardt. (2017). “Green tea effects on cognition, mood and human brain function: A systematic review”. Phytomedicine. 34 : 26–37. 10.1016/j.phymed.2017.07.008.

[67] M. Hilal and S. Hilal. (2017). “Knowledge, attitude, and utilization of herbal medicines by physicians in the Kingdom of Bahrain: A cross-sectional study”. Journal of the Association of Arab Universities for Basic and Applied Sciences. 24 (1): 325–333. 10.1016/j.jaubas.2016.11.001.

[68] S. M. Chacko, P. T. Thambi, R. Kuttan, and I. Nishigaki. (2010). “Beneficial effects of green tea: A literature review”. Chinese Medicine. 5. 10.1186/1749-8546-5-13.

[69] D. Wikoff, B. T. Welsh, R. Henderson, G. P. Brorby, J. Britt, E. Myers, J. Goldberger, H. R. Lieberman, C. O'Brien, J. Peck, M. Tenenbein, C. Weaver, S. Harvey, J. Urban, and C. Doepker. (2017). “Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children”. Food and Chemical Toxicology. 109 : 585–648. 10.1016/j.fct.2017.04.002.

[70] M. Cerbin-Koczorowska, M. Waszyk-Nowaczyk, P. Bakun, T. Goslinski, and T. Koczorowski. (2021). “Current view on green tea catechins formulations, their interactions with selected drugs, and prospective applications for various health conditions”. Applied Sciences (Switzerland). 11 (11): 10.3390/app11114905.

[71] J. D. Lambert, M. J. Kennett, S. Sang, K. R. Reuhl, J. Ju, and C. S. Yang. (2010). “Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice”. Food and Chemical Toxicology. 48 (1): 409–416. 10.1016/j.fct.2009.10.030.

[72] A. H. Schönthal. (2011). “Adverse effects of concentrated green tea extracts”. Molecular Nutrition and Food Research. 55 6: 874–885. 10.1002/mnfr.201000644.

[73] H. A. Oketch-Rabah, A. L. Roe, C. V. Rider, H. L. Bonkovsky, G. I. Giancaspro, V. Navarro, M. F. Paine, J. M. Betz, R. J. Marles, S. Casper, B. Gurley, S. A. Jordan, K. He, M. P. Kapoor, T. P. Rao, A. H. Sherker, R. J. Fontana, S. Rossi, R. Vuppalanchi, L. B. Seeff, A. Stolz, J. Ahmad, C. Koh, J. Serrano, T. Low Dog, and R. Ko. (2020). “United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts”. Toxicology Reports. 7 : 386–402. 10.1016/j.toxrep.2020.02.008.

Downloads

Published

2022-04-16

How to Cite

[1]
S. Ratnani and S. Malik, “Therapeutic Properties of Green Tea: A Review”, J. Multidiscip. Appl. Nat. Sci., vol. 2, no. 2, pp. 90-102, Apr. 2022.

Issue

Vol. 2 No. 2 (2022): Journal of Multidisciplinary Applied Natural Science

Section

Articles

License

Copyright (c) 2022 Sonia Ratnani, Sarika Malik

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and acknowledge that the Journal of Multidisciplinary Applied Natural Science is the first publisher, licensed under a Creative Commons Attribution License.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges and earlier and greater citation of published work.